| 摘要 |
The invention relates to compounds in particular N,N-dimethyl acetamide and 1-vinyl-2- pyrrolidone, for use in a method for prevention or treatment of a disease that can be modulated or ameliorated by the inhibition of bromodomain containing proteins and enhancement of bone morphogenetic protein receptor signalling. In particular these diseases comprise weight gain, obesity, osteoporosis, osteoarthritis, periodontitis and/or peri- implantitis. |
